Low-dose doxepin formulations and methods of making and using the same

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9532971
SERIAL NO

13898364

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention disclosed herein generally relates to low-dose oral doxepin pharmaceutical formulations and the use of these formulations to promote sleep.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • PERNIX SLEEP, INC.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Carter, John Keswick, CA 117 2769
Casseday, Cara Baron San Diego, US 11 46
Dorsey, Brian Talmadge Encinitas, US 6 38
Jochelson, Philip San Diego, US 36 338
Knox, Bryan San Diego, US 6 38
Mansbach, Robert San Diego, US 15 151
Perry, Meredith San Diego, US 35 3063
Rogowski, Roberta L Rancho Santa Fe, US 28 238
Schioppi, Luigi Escondido, US 8 57
Skinner, Michael San Diego, US 36 337

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 3, 2024
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 3, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00